BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15588506)

  • 1. Hematopoietic cancer and angiogenesis.
    Ribatti D; Scavelli C; Roccaro AM; Crivellato E; Nico B; Vacca A
    Stem Cells Dev; 2004 Oct; 13(5):484-95. PubMed ID: 15588506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and anti-angiogenesis in hematological malignancies.
    Ribatti D; Vacca A; Dammacco F; English D
    J Hematother Stem Cell Res; 2003 Feb; 12(1):11-22. PubMed ID: 12662432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in hematologic malignancies.
    Moehler TM; Neben K; Ho AD; Goldschmidt H
    Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis and hematological malignancies].
    Iversen PO
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis, angiogenic factor expression and hematological malignancies.
    Ribatti D; Vacca A; De Falco G; Roccaro A; Roncali L; Dammacco F
    Anticancer Res; 2001; 21(6B):4333-9. PubMed ID: 11908688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
    Peled A; Klein S; Beider K; Burger JA; Abraham M
    Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiogenesis in chronic lymphocytic leukemia.
    Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
    Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in hematologic malignancies and its clinical implications.
    Yang R; Han ZC
    Int J Hematol; 2002 Apr; 75(3):246-56. PubMed ID: 11999351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical importance of angiogenesis and angiogenic factors in oncohematology].
    Grosicki S; Grosicka A; HoĊ‚owiecki J
    Wiad Lek; 2007; 60(1-2):39-46. PubMed ID: 17607967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic strategies in neuroblastoma.
    Ribatti D; Ponzoni M
    Cancer Treat Rev; 2005 Feb; 31(1):27-34. PubMed ID: 15707702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.
    Lentzsch S; Rogers MS; LeBlanc R; Birsner AE; Shah JH; Treston AM; Anderson KC; D'Amato RJ
    Cancer Res; 2002 Apr; 62(8):2300-5. PubMed ID: 11956087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approach.
    Eleutherakis-Papaiakovou V; Karali M; Kokkonouzis I; Tiliakos I; Dimopoulos MA
    Leuk Lymphoma; 2003 Jun; 44(6):937-48. PubMed ID: 12854891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis and hematologic malignancy].
    Zini JM; Tobelem G
    Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
    Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
    Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiogenesis and endothelial cells in blood neoplasms].
    Usnarska-Zubkiewicz L; Poreba M; Kuliczkowski K
    Przegl Lek; 2006; 63(3):146-50. PubMed ID: 16969900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of thalidomide in the treatment of cancer.
    Rajkumar SV
    Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenesis in haematological malignancies.
    Li WW; Hutnik M; Gehr G
    Br J Haematol; 2008 Dec; 143(5):622-31. PubMed ID: 19036013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiogenesis in hematologic malignancies.
    Stasi R; Amadori S
    J Hematother Stem Cell Res; 2002 Feb; 11(1):49-68. PubMed ID: 11847003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.